We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
$550-MILLION STUDY : South Africa included in Gates-led clinical trial of new TB vaccine hailed as potential game-changer
Law Law Headlines News
A Phase 3 clinical trial for M72, a new candidate vaccine against pulmonary tuberculosis will be conducted in South Africa. The head of Global Health at the Bill & Melinda Gates Foundation, Dr Trevor Mundel, said this week that they were very optimistic...